Sonnet BioTherapeutics Holdings, Inc. Soared
Mon, Jul 14, 2025 at 07:26 PM
Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ) shot up at $9.64, representing a gain of 86.5%. On Mon, Jul 14, 2025, SONN:NASDAQ touched a New 2-Week High of $9.64. The stock appeared on our News Catalysts scanner on Mon, Jul 14, 2025 at 07:44 AM in the 'MERGER' category. From Mon, Jun 30, 2025, the stock recorded 55.56% Up Days and 50.00% Green Days
The stock spiked on Mon, Jul 14, 2025 at $19 with a volume of 44M+.
About Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ)
Sonnet BioTherapeutics Holdings Inc is a biotechnology company engaged in the development of biologic drugs focused on human antibody binding technology. The firm's pipeline products include SON-080 (low-dose IL-6), SON-081 (low dose IL-6), SON-1010 (IL12-FHAB), and others.
Top 10 Gainers:
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 160%
- TROOPS, Inc. (TROO:NASDAQ), 104.58%
- Stardust Power Inc. (SDST:NASDAQ), 88.29%
- Sonnet BioTherapeutics Holdings, Inc. (SONN:NASDAQ), 86.46%
- Monogram Technologies Inc. (MGRM:NASDAQ), 78.42%
- LQR House Inc. (YHC:NASDAQ), 76.92%
- Innovation Beverage Group Limited (IBG:NASDAQ), 74.58%
- DDC Enterprise Limited (DDC:NYSEMKT), 53.23%
- SeaChange International, Inc. (SEAC:NASDAQ), 50.54%
- Eyenovia, Inc. (EYEN:NASDAQ), 49.81%